Yes. Seqens is owned by private equity investors Ardian, Eurazeo PME, Merieux Equity Partners and SK Capital Partners.
Yes. Seqens was formerly owned by 2 private investors.
Seqens is headquartered in Ecully, France.
Seqens has 3,200 employees.
Seqens is a chemicals company.
Seqens was founded in 2003.
21 Chemin de la Sauvegarde,
Ecully,
69134
France,
+33 4 26 99 18 00
www.seqens.com
Seqens is a global diversified chemicals Group that produces and distributes essential chemicals that are used in everyday products. Seqens offers a broad portfolio of active ingredients, pharmaceutical intermediates, and specialty ingredients, develops and industrializes the most demanding molecules, and relies on its ability to innovate, develop and implement the best available technologies. Seqens was founded in 2003 and is based in Ecully, France.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.4/yr) | # | 3 | 1 | - | 1 | - | - | 5 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 5 | ||||||||
| Legal | Deals |
|---|---|
|
Ashurst |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
